The Feasibility and Safety of Day Case Brain Tumour Biopsy: An Eight-Year Experience in the United Kingdom
International Journal of Neurosurgery · 31.10.2023 · 7 (2) · 46-51
DOI: 10.11648/j.ijn.20230702.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neurosurgery, online erschienen am 31.10.2023. Verfasst von William Bolton und 7 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Purpose
Day-case surgery for selected procedures has the potential to reduce healthcare costs and improve patient experience. In neurosurgery, brain biopsies have been performed as day-case procedures for selected patients. The purpose of this study is to demonstrate the safety and feasibility of a clinical pathway that facilitates day-case brain biopsy surgery to improve the generalisability of the evidence and inform wider adoption of this practice. Materials and methods: A single centre, retrospective study of patients aged ≥18 years requiring a brain biopsy for presumed tumour between November 2009 and December 2017 was performed. All patients received pre-admission radiology imaging +/- trajectory planning (as required), an operation on a morning theatre list and post-biopsy CT head 4-6 hours to rule out haemorrhage or other complications. Discharge was aimed at 6 hours post-biopsy if observations and CT were satisfactory. All data was collected via an institution operative database and descriptive statistical analysis was conducted.
Results
A total of 447 brain tumour biopsies performed over the eight-year study period of which a total of n=160 (35.8%) were planned day-case. The proportion of biopsies performed as day-case increased over the study period, from four in 2009 to 33 per annum in 2017, an increase from only 10% (n=4) to 66% (n=33) of the total annual biopsies for this centre. Of the 160 planned day-cases, 135 (84.4%) were actual day-cases and successfully discharged on the same day as the operation. The mean patient age was 58 years. Twenty-five cases had at least one overnight unplanned stay, revealing a failure rate of 15.6%.
Conclusions
This study demonstrates the safety of our day-case brain tumour biopsy service and is consistent with other centres’ experiences. This represents an opportunity for neurosurgeons to confidently contribute to an increasing provision of day-case surgery across the service.
Zitieren
APA
Bolton, W., Saeed, F., Solanki, S., Sivakumar, G., Corns, R., Goodden, J., Chumas, P., & Thomson, S. (2023). The Feasibility and Safety of Day Case Brain Tumour Biopsy: An Eight-Year Experience in the United Kingdom. International Journal of Neurosurgery, 7(2), 46-51. https://doi.org/10.11648/j.ijn.20230702.16
Vancouver
Bolton W, Saeed F, Solanki S, Sivakumar G, Corns R, Goodden J, et al. The Feasibility and Safety of Day Case Brain Tumour Biopsy: An Eight-Year Experience in the United Kingdom. International Journal of Neurosurgery. 2023;7(2):46-51. doi:10.11648/j.ijn.20230702.16
BibTeX
@article{Bolton2023,
author = {Bolton, William and Saeed, Fozia and Solanki, Sandeep and Sivakumar, Gnanamurthy and Corns, Robert and Goodden, John and Chumas, Paul and Thomson, Simon},
title = {The Feasibility and Safety of Day Case Brain Tumour Biopsy: An Eight-Year Experience in the United Kingdom},
journal = {International Journal of Neurosurgery},
year = {2023},
volume = {7},
number = {2},
pages = {46--51},
doi = {10.11648/j.ijn.20230702.16}
}
EUVIMED